What is Tango Therapeutics, Inc.'s Market Cap?

Tango Therapeutics, Inc.'s Market Cap is $4.0B, based on as-reported figures from SEC (XBRL) filings.

What is Tango Therapeutics, Inc.'s Enterprise Value?

Tango Therapeutics, Inc.'s Enterprise Value is $3.0B, based on as-reported figures from SEC (XBRL) filings.

What is Tango Therapeutics, Inc.'s Price / Sales?

Tango Therapeutics, Inc.'s Price / Sales is 74.3×, based on as-reported figures from SEC (XBRL) filings.

What is Tango Therapeutics, Inc.'s EV / Revenue?

Tango Therapeutics, Inc.'s EV / Revenue is 55.5×, based on as-reported figures from SEC (XBRL) filings.

What is Tango Therapeutics, Inc.'s EV / EBITDA?

Tango Therapeutics, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Tango Therapeutics, Inc.'s Revenue (TTM)?

Tango Therapeutics, Inc.'s Revenue (TTM) is $53.8M, based on as-reported figures from SEC (XBRL) filings.

What is Tango Therapeutics, Inc.'s Net Income (TTM)?

Tango Therapeutics, Inc.'s Net Income (TTM) is -$123.7M, based on as-reported figures from SEC (XBRL) filings.

What is Tango Therapeutics, Inc.'s EBITDA?

Tango Therapeutics, Inc.'s EBITDA is -$134.4M, based on as-reported figures from SEC (XBRL) filings.

What is Tango Therapeutics, Inc.'s Diluted EPS (TTM)?

Tango Therapeutics, Inc.'s Diluted EPS (TTM) is -0.73, based on as-reported figures from SEC (XBRL) filings.

What is Tango Therapeutics, Inc.'s EBITDA Margin?

Tango Therapeutics, Inc.'s EBITDA Margin is -249.8%, based on as-reported figures from SEC (XBRL) filings.

Tango Therapeutics, Inc. (TNGX) Financial Statements

Tango Therapeutics, Inc.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00WFDDSK6

XNAS · usd

23.73▲ 1.03 (4.52%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close22.70

Day's Range22.26 – 23.08

52-Week Range6.25 – 34.39

Volume2.4M

Avg Volume2.0M

Share Statistics

Shares Outstanding

Employees137

ExchangeXNAS

Listed2021-08-11

Share count as of August 4, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Tango Therapeutics, Inc. (TNGX)

What is Tango Therapeutics, Inc.'s Market Cap?: Tango Therapeutics, Inc.'s Market Cap is $4.0B, based on as-reported figures from SEC (XBRL) filings.
What is Tango Therapeutics, Inc.'s Enterprise Value?: Tango Therapeutics, Inc.'s Enterprise Value is $3.0B, based on as-reported figures from SEC (XBRL) filings.
What is Tango Therapeutics, Inc.'s Price / Sales?: Tango Therapeutics, Inc.'s Price / Sales is 74.3×, based on as-reported figures from SEC (XBRL) filings.
What is Tango Therapeutics, Inc.'s EV / Revenue?: Tango Therapeutics, Inc.'s EV / Revenue is 55.5×, based on as-reported figures from SEC (XBRL) filings.
What is Tango Therapeutics, Inc.'s EV / EBITDA?: Tango Therapeutics, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Tango Therapeutics, Inc.'s Revenue (TTM)?: Tango Therapeutics, Inc.'s Revenue (TTM) is $53.8M, based on as-reported figures from SEC (XBRL) filings.
What is Tango Therapeutics, Inc.'s Net Income (TTM)?: Tango Therapeutics, Inc.'s Net Income (TTM) is -$123.7M, based on as-reported figures from SEC (XBRL) filings.
What is Tango Therapeutics, Inc.'s EBITDA?: Tango Therapeutics, Inc.'s EBITDA is -$134.4M, based on as-reported figures from SEC (XBRL) filings.
What is Tango Therapeutics, Inc.'s Diluted EPS (TTM)?: Tango Therapeutics, Inc.'s Diluted EPS (TTM) is -0.73, based on as-reported figures from SEC (XBRL) filings.
What is Tango Therapeutics, Inc.'s EBITDA Margin?: Tango Therapeutics, Inc.'s EBITDA Margin is -249.8%, based on as-reported figures from SEC (XBRL) filings.